Richard Peters
Chairman bij APREA THERAPEUTICS, INC.
Vermogen: 43 760 $ op 31-03-2024
Profiel
Dr. Richard Peters is a Chairman at Pharming Group NV, a Lead Independent Director at Kineta, Inc., a Chairman at Aprea Therapeutics, Inc., an Executive Chairman at Tellbio, Inc. and a President, Chief Executive Officer & Director at Yumanity, Inc. He is on the Board of Directors at Kineta, Inc. and Yumanity, Inc. Dr. Peters was previously employed as a President, Chief Executive Officer & Director by Yumanity Therapeutics, Inc., a President, Chief Executive Officer & Director by Merrimack Pharmaceuticals, Inc., a Founder by X4 Pharmaceuticals, Inc. /Old/, a Co-Founder by X4 Pharmaceuticals, Inc., a Senior Vice President & Head-Global Rare Diseases by Genzyme Corp., a Senior Director by Onyx Pharmaceuticals, Inc., a Director-Medical Affairs by Amgen, Inc., and a Chief Executive Officer by MedNav, Inc. He also served on the board at PIC Therapeutics, Inc. He received his undergraduate degree from the College of Charleston and a doctorate degree from Medical University of South Carolina.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PHARMING GROUP NV
0.00% | 31-03-2024 | 27 504 ( 0.00% ) | 30 269 $ | 31-03-2024 |
APREA THERAPEUTICS, INC.
0.02% | 23-08-2023 | 1 029 ( 0.02% ) | 6 884 $ | 31-03-2024 |
KINETA, INC.
0.11% | 12-04-2023 | 12 585 ( 0.11% ) | 6 607 $ | 31-03-2024 |
Actieve functies van Richard Peters
| Bedrijven | Functie | Begin |
|---|---|---|
| APREA THERAPEUTICS, INC. | Chairman | 23-08-2023 |
| KINETA, INC. | Director/Board Member | 19-12-2022 |
| PHARMING GROUP N.V. | Chairman | 25-09-2023 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Chief Executive Officer | - |
Tellbio, Inc.
 Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | Founder | - |
Eerdere bekende functies van Richard Peters
| Bedrijven | Functie | Einde |
|---|---|---|
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Founder | 01-06-2022 |
| YUMANITY THERAPEUTICS | Chief Executive Officer | 01-01-2022 |
| MERRIMACK PHARMACEUTICALS, INC. | Chief Executive Officer | 28-06-2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2017 |
| ░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Richard Peters
| Medical University of South Carolina | Doctorate Degree |
| College of Charleston | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| PHARMING GROUP N.V. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
MedNav, Inc.
 MedNav, Inc. Packaged SoftwareTechnology Services MedNav, Inc. develops mobile health applications. | Technology Services |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Health Technology |
Tellbio, Inc.
Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | Health Technology |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
| Kineta, Inc. |
